Bell Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7K | Sell |
28
-15
| -35% | -$7.88K | ﹤0.01% | 526 |
|
|
2025
Q1 | $27.3K | Buy |
43
+12
| +39% | +$7.61K | 0.01% | 317 |
|
|
2024
Q4 | $22.1K | Sell |
31
-7
| -18% | -$4.99K | ﹤0.01% | 362 |
|
|
2024
Q3 | $39.9K | Hold |
38
| – | – | 0.01% | 257 |
|
|
2024
Q2 | $39.9K | Buy |
38
+1
| +3% | +$1.05K | 0.01% | 251 |
|
|
2024
Q1 | $35.6K | Buy |
37
+2
| +6% | +$1.93K | 0.01% | 262 |
|
|
2023
Q4 | $30.7K | Sell |
35
-3
| -8% | -$2.64K | 0.01% | 263 |
|
|
2023
Q3 | $31.3K | Buy |
38
+1
| +3% | +$823 | 0.01% | 236 |
|
|
2023
Q2 | $26.6K | Sell |
37
-2
| -5% | -$1.44K | 0.01% | 255 |
|
|
2023
Q1 | $32K | Hold |
39
| – | – | 0.01% | 221 |
|
|
2022
Q4 | $28.1K | Buy |
39
+3
| +8% | +$2.16K | 0.01% | 242 |
|
|
2022
Q3 | $25K | Buy |
36
+10
| +38% | +$6.94K | 0.01% | 227 |
|
|
2022
Q2 | $15K | Buy |
+26
| New | +$15K | ﹤0.01% | 331 |
|
|
2021
Q4 | $15K | Sell |
23
-1
| -4% | -$652 | ﹤0.01% | 375 |
|
|
2021
Q3 | $15K | Buy |
+24
| New | +$15K | ﹤0.01% | 357 |
|